Alan Edrick - Mar 14, 2023 Form 4 Insider Report for HARVARD BIOSCIENCE INC (HBIO)

Role
Director
Signature
/s/ David Sirois, by power of attorney
Stock symbol
HBIO
Transactions as of
Mar 14, 2023
Transactions value $
$79,290
Form type
4
Date filed
3/16/2023, 06:02 PM
Previous filing
Jan 4, 2023
Next filing
May 23, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HBIO Common Stock Purchase $36.9K +13.8K +8.01% $2.67 186K Mar 14, 2023 Direct F1
transaction HBIO Common Stock Purchase $42.4K +16.2K +8.69% $2.62 202K Mar 15, 2023 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $2.61 to $2.72, inclusive. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
F2 This transaction was executed in multiple trades at prices ranging from $2.57 to $2.68, inclusive. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 Includes (a) 38,259 restricted stock units that fully vest on the earlier to occur of (i) the date of the Issuer's next Annual Meeting of Stockholders after May 17, 2022, immediately prior to the commencement of such meeting, and (ii) May 24, 2023 and (b) 164,226 shares of common stock held by the Report Person.